Paper · 42383990
Blockade of FGFR1 Trafficking to the Cell Surface Results in the Partial Mistargeting of the Receptor to Peroxisomes.
Działek P and 5 others. FASEB J, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Blockade of FGFR1 Trafficking to the Cell Surface Results in the Partial Mistargeting of the Receptor to Peroxisomes. Papers, record 42383990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42383990
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Blockade of FGFR1 Trafficking to the Cell Surface Results in the Partial Mistargeting of the Receptor to Peroxisomes.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Peroxisomes | Major topic |
| Receptor, Fibroblast Growth Factor, Type 1 | Major topic |
| Cell Membrane | Major topic |
| Humans | |
| Protein Transport | |
| Animals | |
| Endoplasmic Reticulum | |
| Mitochondria | |
| Glycosylation |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2019/34/E/NZ3/00014 | Narodowe Centrum Nauki (NCN) | PubMed | ||
| FENG.02.02-IP.05-0015 | Fundacja na rzecz Nauki Polskiej (FNP) | PubMed | ||
| BPN/BCH/2025/1/00007/U/00001 | Narodowa Agencja Wymiany Akademickiej (NAWA) | PubMed | ||
| 2026YFE0153800 | International Science and Technology Innovation Cooperation Key Project of China | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,393,834 | STAMBPL1 promotes the progression of lung adenocarcinoma by inhibiting DHRS2 expression. | Transl Oncol | 2023 | https://conductscience.org/library/papers/37393834 | PubMed |
| 2 | 20,547,751 | Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53. | Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20547751 | PubMed |
| 3 | 12,706,718 | Prediction of peroxisomal targeting signal 1 containing proteins from amino acid sequence. | J Mol Biol | 2003 | https://conductscience.org/library/papers/12706718 | PubMed |
| 4 | 38,831,455 | Targeting FGFR for cancer therapy. | J Hematol Oncol | 2024 | https://conductscience.org/library/papers/38831455 | PubMed |
| 5 | 31,291,971 | DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31291971 | PubMed |
| 6 | 33,652,058 | Emerging roles of dehydrogenase/reductase member 2 (DHRS2) in the pathology of disease. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/33652058 | PubMed |
| 7 | 30,268,746 | Yeast peroxisomes: How are they formed and how do they grow? | Int J Biochem Cell Biol | 2018 | https://conductscience.org/library/papers/30268746 | PubMed |
| 8 | 37,552,037 | Import and quality control of peroxisomal proteins. | J Cell Sci | 2023 | https://conductscience.org/library/papers/37552037 | PubMed |
| 9 | 25,760,602 | The 1.65 Å resolution structure of the complex of AZD4547 with the kinase domain of FGFR1 displays exquisite molecular recognition. | Acta Crystallogr D Biol Crystallogr | 2015 | https://conductscience.org/library/papers/25760602 | PubMed |
| 10 | 23,414,306 | Peroxisome formation and maintenance are dependent on the endoplasmic reticulum. | Annu Rev Biochem | 2013 | https://conductscience.org/library/papers/23414306 | PubMed |
1 to 10 of 61
See all 61 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DHRS2 | 10,202 | PubTator's text mining | https://conductscience.org/library/genes/10202 | NCBI Gene |
| FGFR1 | 2,260 | PubTator's text mining | https://conductscience.org/library/genes/2260 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42383990
GET https://conductscience.org/api/papers/v1/42383990/references?page=2